Poly(e{open}-caprolactone), Eudragit® RS 100 and poly(e{open}-caprolactone)/Eudragit® RS 100 blend submicron particles for the sustained release of the antiretroviral efavirenz

Colloids and Surfaces B: Biointerfaces

Volumn 102, Issue , 2013, Pages 441-449

  Seremeta, Katia P ^a,b   Chiappetta, Diego A ^a,b   Sosnik, Alejandro ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

Author keywords

Antiretrovirals; Controlled release in vitro; Drug delivery systems; Efavirenz loaded poly(e open caprolactone), Eudragit RS 100 and poly(e open caprolactone) Eudragit RS 100 blend submicron particles; HIV infection

Indexed keywords

ANTIRETROVIRALS; CAPROLACTONE; DRUG DELIVERY SYSTEM; HIV INFECTION; IN-VITRO;

BIOCHEMISTRY; DRUG DELIVERY; ENCAPSULATION; POLYACRYLATES;

DRUG PRODUCTS;

EFAVIRENZ; EUDRAGIT RS; NANOPARTICLE; POLYCAPROLACTONE; ANTIVIRUS AGENT; BENZOXAZINE DERIVATIVE; DRUG CARRIER; METHYLMETHACRYLATE METHACRYLIC ACID COPOLYMER; METHYLMETHACRYLATE-METHACRYLIC ACID COPOLYMER; POLYESTER; POLYMETHACRYLIC ACID DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG DIFFUSION; DRUG INTERACTION; DRUG STABILITY; IN VITRO STUDY; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY;

ANTIVIRAL AGENTS; BENZOXAZINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; POLYESTERS; POLYMETHACRYLIC ACIDS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84866485610     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.06.038     Document Type: Article

References (73)

1. AIDS Epidemic Update 2007, World Health Organization. (accessed 07.2009). http://www.who.int/hiv/epiupdates/en/index.html.
2. Panel on Clinical Practices for Treatment of HIV Infection Pan. Am. J. Public Health 2001, 10:426.
3. UNAIDS/WHO AIDS Epidemic. (accessed 07.2009). http://www.unaids.org/en/HIV.
4. Delaney M. Retrovirology 2006, 3:S6.
5. Andrews L., Friedland G. Infect. Dis. Clin. North Am. 2000, 14:1.
6. Romanelli F., Hoven A.D. Curr. Pharm. Des. 2006, 12:1121.
7. Park S., Sinko P.J. J. Pharmacol. Exp. Ther. 2005, 312:1249.
8. Geeraert L., Kraus G., Pomerantz R.J. Annu. Rev. Med. 2008, 59:487.
9. Peralta G., Sánchez M.B., Echevarría S., Valdizán E.M., Armijo J.A. Enferm. Infecc. Microbiol. Clin. 2008, 26:150.
10. Dean M., Hamon Y., Chimini G. J. Lipid Res. 2001, 42:1007.
11. Higgins C.F. Nature 2007, 446:749.
12. Aungst B.J. Adv. Drug Deliv. Rev. 1999, 39:105.
13. Balimane P.V., Sinko P.J. Adv. Drug Deliv. Rev. 1999, 39:183.
14. Peroni R.N., Di Gennaro S.S., Hocht C., Chiappetta D.A., Rubio M.C., Sosnik A., Bramuglia G.F. Biochem. Pharmacol. 2011, 82:1227.
15. Ronaldson P.T., Persidsky Y., Bendayan R. Glia 2008, 56:1711.
16. Vivithanaporn P., Gill M.J., Power C. Expert Rev. Anti Infect. Ther. 2011, 9:371.
17. Nath A., Sacktor N. Curr. Opin. Neurol. 2006, 19:358.
18. Crews L., Patrick C., Achim C.L., Everall I.P., Masliah E. Int. J. Mol. Sci. 2009, 10:1045.
19. Dash P.K., Gorantla S., Gendelman H.E., Knibbe J., Casale G.P., Makarov E., Epstein A.A., Gelbard H.A., Boska M.D., Poluektova L.Y. J. Neurosci. 2011, 31:3148.
20. Grovit-Ferbas K., Harris-White M.E. Immunol. Res. 2010, 48:40.
21. Van Rie A., Mupuala A., Dow A. Pediatrics 2008, 122:123.
22. Cook-Easterwood J., Middaugh L.D., Griffin W.C., Khan I., Tyor W.R. Exp. Neurol. 2007, 205:506.
23. Sosnik A., Chiappetta D.A., Carcaboso A.M. J. Control. Release 2009, 138:2.
24. Wong H.L., Chattopadhyay N., Wu X.Y., Bendayan R. Adv. Drug Deliv. Rev. 2010, 62:503.
25. Gunaseelan S., Gunaseelan K., Deshmukh M., Zhang X., Sinko P.J. Adv. Drug Deliv. Rev. 2010, 62:518.
26. Chiappetta D.A., Sosnik A. Eur. J. Pharm. Biopharm. 2007, 66:303.
27. Shaik N., Pan G., Elmquist W.F. J. Pharm. Sci. 2008, 97:5421.
28. Shaik N., Giri N., Elmquist W.F. J. Pharm. Sci. 2009, 98:4170.
29. Nowacek A., Gendelman H.E. Nanomedicine (Lond.) 2009, 4:557.
30. Mistry A., Stolnik S., Illum L. Int. J. Pharm. 2009, 379:146.
31. Dhuria S.V., Hanson L.R., Frey W.H. J. Pharm. Sci. 2010, 99:1654.
32. Hanson L.R., Frey W.H. J. Neuroimmune Pharmacol. 2007, 2:81.
33. Illum L. J. Pharm. Pharmacol. 2004, 56:3.
34. Al-Ghananeem A.M., Saeed H., Florence R., Yokel R.A., Malkawi A.H. J. Drug Target. 2010, 18:381.
35. D.A. Chiappetta, C. Hocht, J.A.W. Opezzo, A. Sosnik, Nanomedicine-UK, in press.
36. Perrin D., English J. Polycaprolactone. Handbook of Biodegradable Polymers. Drug Targeting and Delivery 1997, vol. 7:63-77.
37. Kumar N., Ravikumar M.N.V., Domb A.J. Adv. Drug Deliv. Rev. 2001, 53:23.
38. Rathbone M.J., Bunta C.R., Oglea C.R., Burggraafa S., Macmillanb K.L., Pickering K. J. Control. Release 2002, 85:61.
39. Wooddruff M.A., Hutmacher D.W. Prog. Polym. Sci. 2010, 35:1217.
40. Puga A.M., Rico-Rey A., Magariños B., Alvarez-Lorenz C., Concheiro A. Acta Biomater. 2012, 8:1507.
41. Sun H., Mei L., Song C., Cui X., Wang P. Biomaterials 2006, 27:1735.
42. Bourges J.L., Bloquel C., Thomas A., Froussart F., Bochot A., Azan F., Gurny R., BenEzra D., Behar-Cohen F. Adv. Drug Deliv. Rev. 2006, 58:1182.
43. Chawla J.S., Amiji M.M. Int. J. Pharm. 2002, 249:127.
44. Chen J., Ma A., Lai Y., Chen Y., Cui M. J. Biomed. Eng. 1997, 14:334.
45. Eidi H., Joubert O., Attik G., Duval R.E., Bottin M.C., Hamouia A., Maincent P., Rihn B.H. Int. J. Pharm. 2010, 396:156.
46. Schaffazick S.R., Siqueira I.R., Badejo A.S., Jornada D.S., Pohlmann A.R., Netto C.A., Guterres S.S. Eur. J. Pharm. Biopharm. 2008, 69:64.
47. Basarkar A., Singh J. Pharm. Res. 2009, 26:72.
48. Zago A.C., Raudales J.C., Attizzani G., Matte B.S., Yamamoto G.I., Balvedi J.A., Nascimento L., Kosachenco B.G., Centeno P.R., Zago A.J. Catheter. Cardiovasc. Interv. 2012, 10.1002/ccd.24331.
49. Rolland A., Le Verge R., Collet B., Toujas L. J. Pharm. Sci. 1989, 78:781.
50. Lopedota A., Trapani A., Cutrignelli A., Chiarantini L., Pantucci E., Curci R., Manuali E., Trapani G. Eur. J. Pharm. Biopharm. 2009, 72:509.
51. Gotelli G., Bonelli P., Abraham G., Sosnik A. J. Appl. Polym. Sci. 2011, 121:1321.
52. Shah L.K., Amiji M.M. Pharm. Res. 2006, 23:2638.
53. Chiappetta D.A., Hocht C., Taira C., Sosnik A. A Nanomedicine-UK 2010, 5:11.
54. Chiappetta D.A., Alvarez-Lorenzo C., Rey-Rico A., Taboada P., Concheiro A., Sosnik A. Eur. J. Pharm. Biopharm. 2010, 76:24.
55. Chiappetta D.A., Hocht C., Taira C., Sosnik A. Biomaterials 2011, 32:2379.
56. Ritger P.L., Peppas N.A. J. Control. Release 1987, 5:23.
57. Ritger P.L., Peppas N.A. J. Control. Release 1987, 5:37.
58. Sanna V., Roggio A.M., Posadino A.M., Cossu A., Marceddu S., Mariani A., Alzari V., Uzzau S., Pintus G., Sechi M. Nanoscale Res. Lett. 2011, 28:260.
59. Prasad Rao J., Geckeler K.E. Prog. Polym. Sci. 2011, 36:887.
60. Moretton M.A., Glisoni R.J., Chiappetta D.A., Sosnik A. Colloids Surf. B: Biointerfaces 2010, 79:467.
61. Song K.C., Lee H.S., Choung I.Y., Cho K.I., Ahn Y., Choi E.J. Colloids Surf. A: Physicochem. Eng. Aspects 2006, 276:162.
62. Zhao J., Liu C.S., Yuan Y., Tao X.Y., Shan X.Q., Sheng Y., Wu F. Biomaterials 2007, 28:1414.
63. Lince F., Marchisio D.L., Barresi A.A. J. Colloid Interface Sci. 2008, 322:505.
64. Chernysheva Y.V., Babak V.G., Kildeeva N.R., Boury F., Benoit J.P., Ubrich N., Maincent P. Mendeleev Commun. 2003, 13:65.
65. Javadzadeh Y., Ahadi F., Davaran S., Mohammadi G., Sabzevari A., Adibkia K. Colloids Surf. B: Biointerfaces 2010, 81:498.
66. Chen Y., Cui G., Zhao M., Wang C., Qian K., Morris-Natschke S., Lee K.-H., Peng S. Bioorg. Med. Chem. 2008, 16:5914.
67. Pawar D., Goyal A.K., Mangal S., Mishra N., Vaidya B., Tiwari S., Jain A.K., Vyas S.P. AAPS J. 2010, 12:130.
68. Wang J., Tabata Y., Morimoto K. J. Control. Release 2006, 113:31.
69. Sosnik A., Cohn D. Polymer 2003, 44:7033.
70. Cohn D., Lando G., Sosnik A., Garty S., Levi A. Biomaterials 2006, 27:1718.
71. Hoffart V., Ubrich N., Simonin C., Babak V., Vigneron C., Hoffman M., Lecompte T., Maincent F. Drug Dev. Ind. Pharm. 2002, 28:1091.
72. Bastakoti B.P., Guragain S., Yokoyama Y., Yusa S.I., Nakashima K. Colloids Surf. B: Biointerfaces 2011, 88:734.
73. Costa P., Sousa Lobo J.M. Eur. J. Pharm. Sci. 2001, 13:123.